“Health-Related Quality of Life in Patients With Metastatic Basal Cell Carcinoma Treated With Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s337, https://doi.org/10.25251/skin.8.supp.337.